Jankovic J
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
Neurotox Res. 2006 Apr;9(2-3):145-8. doi: 10.1007/BF03033933.
Cervical dystonia (CD) is the most common form of focal dystonia treated with botulinum toxin (BoNT) injections. BoNT has been shown in numerous clinical trials to correct the abnormal posture and movement and to markedly reduce pain associated with CD. In addition, BoNT has favorably modified the natural history of the disease by preventing contractures and other complications of CD, such as secondary degenerative changes of the cervical spine and associated radiculopathy. In a long-term follow-up of patients treated for up to 20 years, the duration of response appears to be sustained and the risk of immunoresistance due to blocking antibodies is relatively small. This review provides and update on the treatment of CD with BoNT type A (BOTOX, Dysport, Xeomin and BoNT type B (Myobloc, NeuroBloc.
颈部肌张力障碍(CD)是肉毒杆菌毒素(BoNT)注射治疗的最常见的局限性肌张力障碍形式。众多临床试验表明,BoNT可纠正异常姿势和运动,并显著减轻与CD相关的疼痛。此外,BoNT通过预防CD的挛缩和其他并发症,如颈椎继发退行性改变及相关神经根病,对疾病的自然病程产生了有利影响。在对接受治疗长达20年的患者进行的长期随访中,反应持续时间似乎得以维持,因阻断抗体导致免疫抵抗的风险相对较小。本综述提供了关于A型肉毒毒素(保妥适、迪帕德、泽明)和B型肉毒毒素(迈保生、纽朗)治疗CD的最新情况。